key: cord-0742022-g1vqtlnz authors: Bermejo-Jambrina, Marta; Eder, Julia; Kaptein, Tanja M.; Helgers, Leanne C.; Brouwer, Philip J.M.; van Hamme, John L.; Vlaar, Alexander P.J.; van Baarle, Frank E.H.P.; de Bree, Godelieve J.; Nijmeijer, Bernadien M.; Koostra, Neeltje A.; van Gils, Marit J.; Sanders, Rogier W.; Geijtenbeek, Teunis B. H. title: SARS-CoV-2 Infection and Transmission Depends on Heparan Sulfates and Is Blocked by Low Molecular Weight Heparins date: 2020-08-18 journal: bioRxiv DOI: 10.1101/2020.08.18.255810 sha: 75ec30e114015b205bee5d5781694c166b9d9db2 doc_id: 742022 cord_uid: g1vqtlnz The current pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and new outbreaks worldwide highlight the need for preventive treatments. Although angiotensin converting enzyme 2 (ACE2) is the primary receptor for SARS-CoV-2, we identified heparan sulfate proteoglycans expressed by epithelial cells, alveolar macrophages and dendritic cells as co-receptors for SARS-CoV-2. Low molecular weight heparins (LMWH) blocked SARS-CoV-2 infection of epithelial cells and alveolar macrophages, and virus dissemination by dendritic cells. Notably, potent neutralizing antibodies from COVID-19 patients interfered with SARS-CoV-2 binding to heparan sulfate proteoglycans, underscoring the importance of heparan sulfate proteoglycans as receptors and uncover that SARS-CoV-2 binding to heparan sulfates is an important mechanism for neutralization. These results have imperative implications for our understanding of SARS-CoV-2 host cell entry and reveal an important target for novel prophylactic intervention. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, 50 China in late 2019 and can cause coronavirus disease 2019 , an influenza-51 like disease ranging from mild respiratory symptoms to severe lung injury, multi organ 52 failure and death (1-3). SARS-CoV-2 spread quickly and has caused a pandemic with a 53 severe impact on global health and world economy (4, 5). SARS-CoV-2 is transmitted 54 predominantly via large droplets expelled from the upper respiratory tract through 55 sneezing and coughing (6, 7) and is subsequently taken up via mucosal surfaces of the 56 nose, mouth and eyes (8). SARS-CoV-2 infects epithelial cells in the respiratory tract, such 57 as ciliated mucus secreting bronchial epithelial cells and type 1 pneumocytes in the lung, 58 as well as epithelial cells in the gastrointestinal tract (9, 10). To date, there is no treatment 59 to prevent SARS-CoV-2 infection. Lockdown strategies and social distancing mitigate viral 60 spread but due to negative socioeconomic consequences these are not feasible long-term 61 solutions (11, 12). Recent renewed outbreaks underscore the urgent need for protective 62 strategies specifically targeting SARS-CoV-2 to prevent further dissemination. 63 and MERS-CoV (13). The coronavirus Spike (S) protein is a class I fusion protein that 65 mediates virus entry (14, 15). The S protein consist of two subunits; S1 directly engages 66 via its receptor-binding domain (RBD) with host surface receptors (16, 17) and S2 67 mediates fusion between virus and cell membrane (18, 19) . SARS-CoV-2 uses 68 angiotensin-converting enzyme 2 (ACE2) as its main receptor (13, 20) . ACE2 is a type I 69 integral membrane protein abundantly expressed on epithelial cells lining the respiratory 70 tract (21) but also the ileum, esophagus and liver (22) and ACE2 expression dictates 71 SARS-CoV-2 tropism (10). However, it remains unclear whether SARS-CoV2 requires 72 other receptors for virus entry. Neutralizing monoclonal antibodies against SARS-CoV-2 73 have been identified that are directed not only at the RBD but also outside the RBD (23) Human kidney epithelial 293T cells with ectopic expression of ACE2 have been used by 115 different studies to investigate the role of ACE2 in SARS-CoV-2 infection ((20, 32) and 116 Supplementary Fig. 1C ). Ectopic expression of ACE2 on 293T cells rendered these cells 117 susceptible to SARS-CoV-2 pseudovirus infection but infection was abrogated by both 118 LMWH enoxaparin and UF heparin to a similar level as antibodies against ACE2 (Fig. 3A) . 119 The combination of ACE2 antibodies and LMWH enoxaparin or UF heparin fully blocked 120 infection of 293T-ACE2 cells (Fig. 3A) . These data strongly suggest that heparan sulfates 121 play a crucial role in SARS-CoV-2 infection. against ACE2 (Fig. 3C ). Combining ACE2 antibodies with UF heparin or LMWH 130 enoxaparin did not further increase block in non-polarized Caco2 ( Fig. 3B and C). Next 131 we cultured Caco-2 cells on a microporous filter and infected the cells with SARS-CoV-2 132 pseudovirus once they had formed a highly polarized epithelial monolayer. The polarized 133 Caco-2 cells were permissive to infection, which was significantly blocked by LMWH 134 treatment to a similar level as antibodies against ACE2 (Fig. 3D) . The combination of an 135 antibody against ACE2 together with LMWH enoxaparin showed the same pattern as each 136 treatment independently (Fig. 3D) . These data suggest that heparan sulfates are required 137 for SARS-CoV-2 infection of (non-)polarized epithelial cells. HuH7.5, 293T(+hACE2) and undifferentiated Caco2 were exposed to 95 ng of 362 pseudotyped SARS-CoV-2 and polarized Caco2 cells to 477.62 ng of pseudotyped SARS-363 CoV-2. Virus was pre-incubated with 250U LMWH or UF heparin prior to addition of cells. A pneumonia outbreak associated with a new coronavirus of probable bat 472 origin COVID-19 pathophysiology: A review A Novel Coronavirus from Patients with Pneumonia in China The socio-economic implications of the coronavirus pandemic (COVID-478 19): A review World Health Organization (2020) Timeline of WHO's response to COVID-19 COVID-19): A literature review Protecting healthcare workers from SARS-CoV-2 infection: practical 483 indications The severe acute respiratory syndrome. 485 Tropism, replication competence, and innate immune responses of the 487 coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo 488 and in-vitro cultures SARS-CoV-2 productively infects human gut enterocytes Are we all in this together? Longitudinal assessment of 492 cumulative adversities by socioeconomic position in the first 3 weeks of lockdown in the 493 UK The psychological impact of quarantine and how to reduce it: rapid 495 review of the evidence Functional assessment of cell entry and receptor usage 497 for SARS-CoV-2 and other lineage B betacoronaviruses Coronavirus Spike Protein and Tropism Changes The coronavirus spike protein is a 501 class I virus fusion protein: structural and functional characterization of the fusion core 502 complex Structure of SARS coronavirus spike receptor-binding 504 domain complexed with receptor Structure of MERS-CoV spike receptor-binding domain complexed with 506 human receptor DPP4 Coronavirus cell entry occurs through the endo-/lysosomal pathway in a 508 proteolysis-dependent manner Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent 510 pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to 511 mediate membrane fusion SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked 513 by a Clinically Proven Protease Inhibitor Tissue distribution of ACE2 protein, the functional receptor for SARS 515 coronavirus. A first step in understanding SARS pathogenesis Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals 518 the potential risk of different human organs vulnerable to 2019-nCoV infection Potent neutralizing antibodies from COVID-19 patients define 521 multiple targets of vulnerability Mediation of human immunodeficiency virus type 1 binding by 523 interaction of cell surface heparan sulfate proteoglycans with the V3 region of envelope 524 gp120-gp41 Human coronavirus NL63 utilizes heparan sulfate proteoglycans for 526 attachment to target cells Hepatitis C virus attachment mediated by apolipoprotein E binding to cell 528 surface heparan sulfate Binding of Sindbis virus to cell surface heparan sulfate Syndecan 4 Upregulation on Activated Langerhans Cells Counteracts 532 Langerin Restriction to Facilitate Hepatitis C Virus Transmission Low-and ultra-low-molecular-weight heparins Anticoagulant treatment is associated with decreased mortality in severe 537 coronavirus disease 2019 patients with coagulopathy Pharmacological and clinical differences between low-molecular-540 weight heparins: implications for prescribing practice and therapeutic interchange Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2 Angiotensin-converting enzyme 2 545 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic 546 target ACE2 receptor expression and severe acute respiratory syndrome 548 coronavirus infection depend on differentiation of human airway epithelia Comparative replication and immune activation profiles of SARS-CoV-2 and 551 SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of 552 COVID-19 HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells Receptor usage dictates HIV-1 restriction by human TRIM5α in 557 dendritic cell subsets DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and 559 the S protein of severe acute respiratory syndrome coronavirus Langerin is a natural barrier to HIV-1 transmission by Langerhans cells Human immature Langerhans cells restrict CXCR4-using HIV-564 1 transmission Origin, homeostasis and function of Langerhans cells and 566 other langerin-expressing dendritic cells DC-SIGN, a dendritic cell-specific HIV-1-binding protein that 568 enhances trans-infection of T cells Syndecan-1 and syndecan-2 play key roles in herpes simplex virus type-1 570 infection Syndecan-1 expression in 572 epithelial cells is induced by transforming growth factor beta through a PKA-dependent 573 pathway Molecular functions of syndecan-1 in disease The 2019 coronavirus (SARS-CoV-2) surface protein (Spike) Receptor Binding Domain undergoes conformational change upon heparin binding Unfractionated heparin potently inhibits the 580 binding of SARS-CoV-2 spike protein to a human cell line SARS-CoV-2 spike protein binds heparan sulfate in a length-and sequence-583 dependent manner SARS-CoV-2 and viral sepsis: observations and hypotheses Dendritic-cell trafficking to lymph nodes through 587 lymphatic vessels Dendritic-cell interactions with HIV: infection and viral 589 dissemination Syndecan-1 induction in lung microenvironment supports the 591 establishment of breast tumor metastases Syndecan-1 serves as the major receptor for attachment of 593 hepatitis C virus to the surfaces of hepatocytes Syndecan-3 is a dendritic cell-specific attachment receptor for HIV-1 Prevention and Treatment of Venous Thromboembolism Associated with 597 Infection: A Consensus Statement before Guidelines World Health Organization (2020) Clinical management of COVID-19. Interim guidance 27 600 Membrane heparan sulfate proteoglycan-supported 602 FGF2-FGFR1 signaling: evidence in support of the "cooperative end structures" model Complete replication of hepatitis C virus in cell culture Rational Design of DNA-Expressed Stabilized Native-Like HIV-1 Envelope 607 Measles virus suppresses RIG-I-like receptor activation in dendritic 609 cells via DC-SIGN-mediated inhibition of PP1 phosphatases incubation with Dispase II (1 U/ml, Roche Diagnostics), epidermal sheets were separated 373 from dermis, washed and cultured in IMDM (Thermo Fischer Scientific, USA) 374 supplemented with 10% FCS, gentamycine (20 μg/ml, Centrafarm, Netherlands), 375 pencilline/streptomycin (10 U/ml and 10 μg/ml, respectively; Invitrogen) for 3 days after 376 which LCs were harvested. Purity of LCs was routinely verified by flow cytometry using 377 antibodies directed against CD207 (langerin) and CD1a. Transmission assays and co-culture 393 Alveolar macrophages, DCs or LCs were exposed to 191.05 ng of pseudotyped SARS-394CoV-2 or pseudotyped SARS-CoV-2 pre-incubated with 250U UF heparin or LMWH for 4 395 hours, harvested, extensively washed to remove unbound virus and co-cultured with 396Huh7.5 for 5 days at 37°C after which they were analyzed for with the Luciferase assay